Literature DB >> 1474545

The selection of a nonsteroidal antiinflammatory drug. Is there a difference?

R F Willkens1.   

Abstract

The availability of an ever expanding number of nonsteroidal antiinflammatory drugs (NSAID) relates to their utility for the treatment of a broad spectrum of disorders. Both the efficacy and adverse effects of NSAID relate primarily to their antiprostaglandin mechanism of action, prostaglandin inhibition. At full antiinflammatory doses, there is little evidence to support a rank order of effectiveness. The major differences among NSAID are their half-lives and safety profiles. With newer agents the emphasis is on safety, especially with respect to gastrointestinal irritation. Acknowledgment of inherent drug differences with respect to pharmacology and safety enhances tolerability by the patient and increases the likelihood for continued drug therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474545

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  3 in total

1.  The drug market in four European countries.

Authors:  S Garattini
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 2.  Differences in NSAID tolerability profiles. Fact or fiction?

Authors:  K J Skeith; M Wright; P Davis
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 3.  Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem.

Authors:  N M Davies; J L Wallace
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.